We discovered that patients with high CTSL expression levels were significantly more likely to have high immune scores, ESTIMATE scores, and stromal cells than patients with low CTSL expression levels (Figure 2A), suggesting that CTSL expression levels in HNSCC patients are correlated with immune status. Here, CTSL is linked to head and neck squamous cell carcinoma.